Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

Companies in the Versant Venture Management portfolio as of December 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Crispr Therapeutics Ag 77.19 4.21M 60.91
Veracyte 10.14 1.21M 27.92
Gritstone Oncology Ord 8.39 3.10M 8.97
Ocular Therapeutix 2.64 2.22M 3.95
Second Sight Med Prods 1.01 4.49M 0.74
Clovis Oncology 0.32 101855 10.43
Cymabay Therapeutics 0.32 543753 1.96

Past 13F-HR SEC Filings by Versant Venture Management

View All Filings